Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: A phase II clinical trial report

Sexually Transmitted Infections

Volumn 84, Issue 5, 2008, Pages 343-347

  Joshi, S N ^a   Dutta, S ^a   Kumar, B K ^a   Katti, U ^a   Kulkarni, S ^a   Risbud, A ^a   Mehendale, S ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CELLULOSE SULFATE; MICROBICIDE; NONOXINOL 9; PLACEBO; PRANEEM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL VAGINOSIS; BURNING MICTURITION; CANDIDIASIS; CERVIX ABRASION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GENITAL DISCOMFORT; GENITAL FOLLICULITIS; GENITAL HERPES; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION PREVENTION; INFORMED CONSENT; MICTURITION DISORDER; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-HIV AGENTS; COHORT STUDIES; CONDOMS; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PLANT EXTRACTS; QUININE; SEXUAL BEHAVIOR; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 53549120907     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.029207     Document Type: Article

References (23)

1. The Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic update. Geneva: UNAIDS, December 2007.
2. Canters for Disease Control. Update: barrier protection against HIV infection and other sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1993:42:589-97.
3. Stone AB, Hitchcock PJ. Vaginal microbicides for preventing the sexual transmission of HIV. AIDS 1994;8(Suppl 1):S285-93.
4. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996;10(Suppl 3):S43-51.
5. Elias CJ, Heise LL. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994;8:1-9.
6. Daar AS, Thorsteinsdottir H, Martin DK, et al. Top ten biotechnologies for improving health in developing countries. Nat Genet 2002;32:229-32.
7. Ramjee G, Shattock R, Delany S, et al. Microbicides 2006 conference. AIDS Res Ther 2006;3:25.
8. Talwar GP, Raghuvanshi P, Mishra R, et al. Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Reprod Immunol 2000;43:144-51.
9. Raghuvanshi P, Bagga R, Malhotra D, et al. Spermicidal and contraceptive properties of Praneem polyherbal pessary. Ind J Med Res 2001;113:135-41.
10. Hazari K, Kalgutkar SD, Palayekar VP, et al. Phase I safety study with Praneem polyherbal vaginal tablet. Abstract no 8-278, Microbicides 2002;1:39.
11. Joshi SN, Katti U, Godbole S, et al. Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India. Trans R Soc Trop Med Hyg 2005;99:769-74.
12. Mauck C, Rosenberg Z, Van Damme L, International Working Group on Microbicides. Recommendations for the clinical development of topical microbicides: an update. AIDS 2001;15:857-68.
13. Nugent RP, Krohn MA, Hillier SL Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
14. Solomon D, Davey D, Kurman R, et al, Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-19.
15. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: WHO, 2001.
16. CONRAD/World Health Organization. Manual for the standardization of colposcopy for the evaluation of vaginally administered products, update. Geneva, Switzerland: CONRAD/WHO, 2000.
17. Mauck C. Introduction: background, issues, and recommendations from the conference. J Acquir Immune Defic Syndr 2004;37(Suppl 3):S143-9.
18. Kilmarx PH, van de Wijgert JH, Chaikummao S, et al. Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a phase II clinical trial. J Acquir Immune Defic Syndr 2006;43:327-34.
19. Joshi S, Dutta S, Bell B, et al. Phase I safety study of 0.5% PRO 2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Res Ther 2006;3:4.
20. Van Damme L, Wright A, Depraetere K, et al. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect 2000;76:126-30.
21. Mayer KH, Karim SA, Kelly C, et al. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV uninfected and abstinent HIV infected women. AIDS 2003;17:321-9.
22. Wilkinson D, Ramjee G, Tholandi M, et al. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev 2002;4:CD003939.
23. The International Working Group on Microbicides. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. J Acquir Immune Defic Syndr 2004;36:541- 52.